Meeting the challenge of hematologic malignancies in sub-Saharan Africa
- PMID: 22461494
- PMCID: PMC4507039
- DOI: 10.1182/blood-2012-02-387092
Meeting the challenge of hematologic malignancies in sub-Saharan Africa
Abstract
Cancer is a leading cause of death and disability in sub-Saharan Africa and will eclipse infectious diseases within the next several decades if current trends continue. Hematologic malignancies, including non-Hodgkin lymphoma, leukemia, Hodgkin lymphoma, and multiple myeloma, account for nearly 10% of the overall cancer burden in the region, and the incidence of non-Hodgkin lymphoma and Hodgkin lymphoma is rapidly increasing as a result of HIV. Despite an increasing burden, mechanisms for diagnosing, treating, and palliating malignant hematologic disorders are inadequate. In this review, we describe the scope of the problem, including the impact of endemic infections, such as HIV, Epstein-Barr virus, malaria, and Kaposi sarcoma-associated herpesvirus. We additionally describe current limitations in hematopathology, chemotherapy, radiotherapy, hematopoietic stem cell transplantation, and supportive care and palliation. We review contemporary treatment and outcomes of hematologic malignancies in the region and outline a clinical service and research agenda, which builds on recent global health successes combating HIV and other infectious diseases. Achieving similar progress against hematologic cancers in sub-Saharan Africa will require the sustained collaboration and advocacy of the entire global cancer community.
Figures
Similar articles
-
Hematologic malignancies in South Africa 2000-2006: analysis of data reported to the National Cancer Registry.Cancer Med. 2016 Apr;5(4):728-38. doi: 10.1002/cam4.597. Epub 2016 Jan 15. Cancer Med. 2016. PMID: 26773310 Free PMC article.
-
Haematological malignancies in sub-Saharan Africa: east Africa as an example for improving care.Lancet Haematol. 2021 Oct;8(10):e756-e769. doi: 10.1016/S2352-3026(21)00198-8. Epub 2021 Sep 2. Lancet Haematol. 2021. PMID: 34481552 Review.
-
Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006.Acta Oncol. 2010 Jun;49(5):694-712. doi: 10.3109/02841861003631495. Acta Oncol. 2010. PMID: 20491526
-
HIV-associated malignancies in sub-Saharan Africa: progress, challenges, and opportunities.Curr Opin HIV AIDS. 2017 Jan;12(1):89-95. doi: 10.1097/COH.0000000000000329. Curr Opin HIV AIDS. 2017. PMID: 27607593 Free PMC article. Review.
-
Mapping the Epidemiology of Kaposi Sarcoma and Non-Hodgkin Lymphoma Among Children in Sub-Saharan Africa: A Review.Pediatr Blood Cancer. 2016 Aug;63(8):1325-31. doi: 10.1002/pbc.26021. Epub 2016 Apr 15. Pediatr Blood Cancer. 2016. PMID: 27082516 Free PMC article. Review.
Cited by
-
Namibia's transition from whole blood-derived pooled platelets to single-donor apheresis platelet collections.Transfusion. 2015 Jul;55(7):1685-92. doi: 10.1111/trf.13049. Epub 2015 Feb 27. Transfusion. 2015. PMID: 25727921 Free PMC article.
-
Gender differences in leukemia outcomes based on health care expenditures using estimates from the GLOBOCAN 2020.Arch Public Health. 2023 Aug 21;81(1):151. doi: 10.1186/s13690-023-01154-8. Arch Public Health. 2023. PMID: 37605241 Free PMC article.
-
Lymphoma and Pathology in Sub-Saharan Africa: Current Approaches and Future Directions.Clin Lab Med. 2018 Mar;38(1):91-100. doi: 10.1016/j.cll.2017.10.007. Epub 2017 Dec 13. Clin Lab Med. 2018. PMID: 29412887 Free PMC article. Review.
-
CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi.PLoS One. 2016 Mar 2;11(3):e0150445. doi: 10.1371/journal.pone.0150445. eCollection 2016. PLoS One. 2016. PMID: 26934054 Free PMC article.
-
Cost utility and budget impact analysis of dexamethasone compared with bortezomib and lenalidomide for the treatment of second line multiple myeloma from a South African public health perspective.Cost Eff Resour Alloc. 2022 Dec 12;20(1):69. doi: 10.1186/s12962-022-00399-4. Cost Eff Resour Alloc. 2022. PMID: 36510230 Free PMC article.
References
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. [Accessed January 2, 2012]. http://globocan.iarc.fr.
-
- Joint United Nations Program on HIV/AIDS (UNAIDS) Global HIV/AIDS response: progress report 2011. [Accessed January 2, 2012]. http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspubl....
-
- World Health Organization. Global tuberculosis control 2011. [Accessed January 2, 2012]. http://www.who.int/tb/publications/global_report/2011/gtbr11_full.pdf.
-
- World Health Organization. World Malaria Report 2010. [Accessed January 2, 2012]. http://www.who.int/malaria/publications/atoz/9789241564106/en/index.html.
-
- Parkin DM. The evolution of the population-based cancer registry. Nat Rev Cancer. 2006;6(8):603–612. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources